T1	Participants 47 95	patients treated for a hematological malignancy.
T2	Participants 187 228	treatment of febrile neutropenic patients
T3	Participants 637 710	1951 febrile neutropenic episodes was the subject of the present analysis
T4	Participants 1784 1821	the clinical condition of the patient
